Rainbow Childrens Medicare Share Price Targets
Rainbow Children's Medicare Limited | |||
 | Price: ₹1,552.50 (+0.28%) | ||
| 52 Week Low: ₹1,129.00 52 Week High: ₹1,709.60 | |||
| Market Capital: 12,637.5 Crore (Midcap) | |||
| Healthcare -> Medical Care Facilities | |||
Rainbow Childrens Medicare Stock Comparison: Rainbow Childrens Medicare vs Jupiter Life Line Hospitals Limited | Rainbow Childrens Medicare vs HealthCare Global Enterprises Limited | Rainbow Childrens Medicare vs INDRAMEDCO | Rainbow Childrens Medicare vs Glenmark Life Sciences | Rainbow Childrens Medicare vs Granules India | Rainbow Childrens Medicare vs Marksans Pharma | |||
Show Table of Contents
Table of Contents
Rainbow Childrens Medicare Recent Performance
Over the past 436 trading days, the value of Rainbow Childrens Medicare's stock has gained ₹543.20 (+53.82%). On 07 Nov 2023, one share was worth ₹1009.30 and by 14 Aug 2025, the value jumped to ₹1552.50. During this period it created a highest high of ₹1709.60 and lowest low of ₹992.95.
Rainbow Childrens Medicare Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 1669.07 (+7.5%) | Price Action: Chart |
| Tomorrow Target 2 | 1637.95 (+5.5%) | Price Action: Oct 2024 High |
| Tomorrow Target 1 | 1620.5 (+4.38%) | Price Action: 25 Jul 2025 High |
| Current Price | 1552.50 | Rainbow Childrens Medicare's share price as of 14 Aug 2025 |
| Stop Loss 1 | 1502.5 (-3.23%) | Price Action: 16 Apr 2025 Low |
| Stop Loss 2 | 1487 (-4.22%) | Price Action: 21 Apr 2025 Low |
| Stop Loss 3 | 1470 (-5.32%) | Price Action: 12 Jun 2025 High |
Summary
14 Aug 2025: Rainbow Childrens Medicare finished the day at ₹1552.50, gaining ₹4.30 (+0.28%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -5.31% to 7.51% with:
- Target prices: ₹1620.5 to ₹1669.07
- Support levels: ₹1502.5 to ₹1470
- Recent high: ₹1565.00
- Recent low: ₹1528.10
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Rainbow Childrens Medicare Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 1620.5 (+4.38%) | Price Action: 25 Jul 2025 High |
| Next Week Target 2 | 1596.85 (+2.85%) | Fibonacci Extension Level 123.60% |
| Next Week Target 1 | 1580.35 (+1.79%) | Fibonacci Extension Level 23.60% |
| Current Price | 1552.50 | Rainbow Childrens Medicare's share price as of 14 Aug 2025 |
| Stop Loss 1 | 1543.3 (-0.6%) | Price Action: 10 Jul 2025 High |
| Stop Loss 2 | 1527.6 (-1.61%) | Price Action: 24 Jul 2025 Low |
| Stop Loss 3 | 1512.2 (-2.6%) | Price Action: 17 Apr 2025 High |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.60% to 4.38% with:
- Upper targets: ₹1580.35 to ₹1620.5
- Support levels: ₹1543.3 to ₹1512.2
Rainbow Childrens Medicare Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 1685.67 (+8.57%) | Price Action: Chart |
| Next Month Target 2 | 1654.24 (+6.55%) | Price Action: Chart |
| Next Month Target 1 | 1637.86 (+5.49%) | Fibonacci Extension Level 23.60% |
| Current Price | 1552.50 | Rainbow Childrens Medicare's share price as of 14 Aug 2025 |
| Stop Loss 1 | 1534.1 (-1.19%) | Price Action: 13 Aug 2025 Low |
| Stop Loss 2 | 1518.7 (-2.18%) | Price Action: Sep 2024 High |
| Stop Loss 3 | 1502.5 (-3.23%) | Price Action: 16 Apr 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -3.22% to 8.58% with:
- Target range: ₹1637.86 to ₹1685.67
- Support levels: ₹1534.1 to ₹1502.5
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
